JPMorgan Chase & Co’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.2K | Sell |
501
-7,273
| -94% | -$467K | ﹤0.01% | 5219 |
|
|
2025
Q1 | $493K | Buy |
7,774
+7,124
| +1,096% | +$452K | ﹤0.01% | 4025 |
|
|
2024
Q4 | $43.2K | Buy |
650
+150
| +30% | +$9.98K | ﹤0.01% | 5058 |
|
|
2024
Q3 | $34.9K | Hold |
500
| – | – | ﹤0.01% | 5082 |
|
|
2024
Q2 | $32.4K | Buy |
+500
| New | +$32.4K | ﹤0.01% | 5038 |
|
|
2023
Q2 | – | Sell |
-31,778
| Closed | -$2M | – | 6210 |
|
|
2023
Q1 | $2M | Buy |
31,778
+3,882
| +14% | +$244K | ﹤0.01% | 3033 |
|
|
2022
Q4 | $1.77M | Buy |
+27,896
| New | +$1.77M | ﹤0.01% | 3039 |
|
|
2021
Q4 | – | Sell |
-403
| Closed | -$30K | – | 5847 |
|
|
2021
Q3 | $30K | Hold |
403
| – | – | ﹤0.01% | 5067 |
|
|
2021
Q2 | $31K | Hold |
403
| – | – | ﹤0.01% | 5052 |
|
|
2021
Q1 | $30K | Hold |
403
| – | – | ﹤0.01% | 4896 |
|
|
2020
Q4 | $28K | Sell |
403
-209
| -34% | -$14.5K | ﹤0.01% | 4542 |
|
|
2020
Q3 | $35K | Hold |
612
| – | – | ﹤0.01% | 4380 |
|
|
2020
Q2 | $36K | Hold |
612
| – | – | ﹤0.01% | 4308 |
|
|
2020
Q1 | $28K | Buy |
+612
| New | +$28K | ﹤0.01% | 4284 |
|
|
2019
Q4 | – | Sell |
-50
| Closed | -$2K | – | 4825 |
|
|
2019
Q3 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 4693 |
|
|
2017
Q4 | – | Sell |
-82
| Closed | -$4K | – | 4712 |
|
|
2017
Q3 | $4K | Hold |
82
| – | – | ﹤0.01% | 4148 |
|
|
2017
Q2 | $4K | Hold |
82
| – | – | ﹤0.01% | 4169 |
|
|
2017
Q1 | $3K | Hold |
82
| – | – | ﹤0.01% | 4318 |
|
|
2016
Q4 | $3K | Sell |
82
-100
| -55% | -$3.66K | ﹤0.01% | 4363 |
|
|
2016
Q3 | $8K | Buy |
182
+100
| +122% | +$4.4K | ﹤0.01% | 3877 |
|
|
2016
Q2 | $3K | Buy |
+82
| New | +$3K | ﹤0.01% | 4034 |
|